Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males

• Status: Completed
• Trial end date: 2007-04-01
• Target enrollment: 0
• Participant gender: Male

Summary

Testosterone replacement treatment is the most effective way of treating hypogonadism in men. Acrux has a proprietry testosterone replacement product - Testosterone-MD Lotion, and this study will evaluate the efficacy and safety of this product.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Acrux DDS Pty Ltd
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Hypogonadal males between 18-70 years old with qualifying general medical health

Exclusion Criteria:

• Disqualifying concurrent conditions or allergy/sensitivity to testosterone replacement therapy